College of Humanities and Social Sciences
Permanent URI for this community
Browse
Browsing College of Humanities and Social Sciences by Author "Emmanuel Ifeanyi Obeagu"
Now showing 1 - 7 of 7
Results Per Page
Sort Options
- ItemAdvancements in Immune Augmentation Strategies for HIV Patients(IAA Journal of Biological Sciences, 2023) Emmanuel Ifeanyi Obeagu; Getrude Uzoma Obeagu; Esther Ugo Alum; Okechukwu Paul-Chima UgwuThe management of HIV has witnessed a transformative shift owing to innovative approaches aimed at bolstering immune status in affected individuals. The landscape of HIV treatment has undergone a profound transformation with the emergence of innovative approaches dedicated to fortifying the immune status of individuals living with the virus. This abstract provides a succinct yet comprehensive overview of groundbreaking strategies aimed at augmenting immune health in HIV patients. Encompassing advancements in immunotherapy, personalized medicine, lifestyle modifications, and telemedicine, this overview highlights the promising trajectory and potential impact of these novel interventions in the realm of HIV care. By exploring the multifaceted dimensions of immune enhancement strategies, this abstract sets the stage for a deeper understanding of these innovative approaches and their pivotal role in shaping the future of HIV management
- ItemAnaemia among pregnant women :A review of African pregnant Teenagers(J Pub Health Nutri, 2023-01-18) Emmanuel Ifeanyi Obeagu; Fortune Chirunim AgreenIn pregnancy, anaemia is when haemoglobin concentration is less than 11 g/dL in the first anthe third trimester or a haemoglobin concentration of less than 10.5 g/dL in the second trimester Globally, anaemia is public health problem since ancient years. During pregnancy, eradicate of anaemia is a key component of safe motherhood. Prevalence of anaemia among pregnant teenagers is high. Microcytic anaemia remains the most common morphological type affecting pregnant teenagers. No formal education and poor antenatal care attendance are associated with an increased risk of anaemia among pregnant teenagers
- ItemAnaemia among pregnant women :prevalence and Determinants(Newport International Journal of Research in Medical Sciences, 2023) Emmanuel Ifeanyi Obeagu; Chidimma Maureen ChukwuezeMalarial infection, occupation, urinary tract infection, place of residence and alcohol consumption are associa anaemia among pregnant women. There is prevalence of anaemia in pregnant women. Anaemia during pregnancy is a public health problem in developed and developing countries. Pregnant women are at risk of developing anaemia due to increased nutrient needs which include iron, folate and Vitamin B12 and haemo-dilution during pregnancy
- ItemAnaemia among pregnant women: A review in Africa(International Digital Organization for Scientific Research, 2023) Emmanuel Ifeanyi Obeagu; Abdi Abubakar Ali; Uche FranciscaOnwuasoanya; Anthonia Onyinye Ngwoke; Danchal Comfort Vandu; Getrude Uzoma Obeagu; Ugwu Okechukwu Paul-ChimaIron-deficiency anemia is the most frequent form of anemia in pregnancy and can have serious consequences for both the mother and fetus. The majority of women do not have adequate iron stores to meet the dramatic increase in requirements during the second and third trimester of pregnancy. However, there is increasing evidence that intravenous iron is more effective, provides more rapid haemoglobin correction, corrects iron stores and is better tolerated than oral iron in treating iron-deficiency anemia during pregnancy. The reported prevalence of anemia in this study is high and routine screening of pregnant women is highly recommended and further studies to explore during pregnancy is a public health problem in developed and developing countries. Pregnant women are at risk of developing anemia due to increased nutrient needs which include iron, folate and Vitamin B12 and haemo-dilution during pregnancy
- ItemAnemia, iron, and HIV: decoding the interconnected pathways A review(Medicine, 2024) Emmanuel Ifeanyi Obeagu; Getrude Uzoma Obeagu; Nkiruka Rose Ukibe; Samson Adewale OyebadejoThis review delves into the intricate relationship between anemia, iron metabolism, and human immunodeficiency virus (HIV), aiming to unravel the interconnected pathways that contribute to the complex interplay between these 3 entities. A systematic exploration of relevant literature was conducted, encompassing studies examining the association between anemia, iron status, and HIV infection. Both clinical and preclinical investigations were analyzed to elucidate the underlying mechanisms linking these components. Chronic inflammation, a hallmark of HIV infection, disrupts iron homeostasis, impacting erythropoiesis and contributing to anemia. Direct viral effects on bone marrow function further compound red blood cell deficiencies. Antiretroviral therapy, while essential for managing HIV, introduces potential complications, including medication-induced anemia. Dysregulation of iron levels in different tissues adds complexity to the intricate network of interactions. Effective management of anemia in HIV necessitates a multifaceted approach. Optimization of antiretroviral therapy, treatment of opportunistic infections, and targeted nutritional interventions, including iron supplementation, are integral components. However, challenges persist in understanding the specific molecular mechanisms governing these interconnected pathways. Decoding the interconnected pathways of anemia, iron metabolism, and HIV is imperative for enhancing the holistic care of individuals with HIV/AIDS. A nuanced understanding of these relationships will inform the development of more precise interventions, optimizing the management of anemia in this population. Future research endeavors should focus on elucidating the intricate molecular mechanisms, paving the way for innovative therapeutic strategies in the context of HIV-associated anemia.
- ItemBenign Prostatic Hyperplasia :A Review(Eurasian Experiment Journal of Public Health, 2023) Emmanuel Ifeanyi Obeagu; U. Alum Esther; Getrude Uzoma Obeagu; Okechukwu Paul-Chima UgwuBenign Prostatic Hyperplasia (BPH) is a noncancerous increase in size of the prostate gland. The symptoms of BPH are mostly lower urinary tract symptoms and these include waking up to urinate at night, urgency, frequency, incontinence of urine and inability to empty the bladder completely and weak urine stream. Nocturia in particular has been found to have negative effect on quality of sleep, energy or vitality. Men realizes they have prostate enlargement when they start experiencing lower urinary tract symptoms. Several new biomarkers for individuals with raised PSA concentrations or those diagnosed with prostate cancer are likely to identify individuals who can be spared aggressive treatment.
- ItemDevelopment of Atherosclerosis in Adulthood: Mini Review(International Digital Organization for Scientific Research :, 2024) Mathias Abiodun Emokpae; Timothy God-Giveth Olusegun; Oluwasina Moses Egbeyemi; Emmanuel Ifeanyi ObeaguThe lipid profile during the neonatal period plays a pivotal role in determining the future risk of atherosclerosis and cardiovascular diseases in adulthood. Abnormal lipid levels in neonates have been associated with an increased Propensity for the development of atherosclerosis later in life. This review aims to explore the significance of Abno mal lipid profiles in neonates and their potential implications for the development of atherosclerosis in adulthood. The discussion encompasses the mechanisms underlying lipid metabolism in early life, the impact of various factors on lipid levels in neonates, and the long-term consequences of abnormal lipid profiles. Understanding relationship between neonatal lipid profiles and the risk of atherosclerosis in adulthood is crucial for developing preventive strategies and interventions aimed at reducing the burden of cardiovascular diseases in later life. This review synthesizes idea from existing literature to provide insights into the importance of early lipid assessment and its implications for long-term cardiovascular health.